Literature DB >> 1337258

Identification and evaluation of new primer sets for the detection of lentivirus proviral DNA.

I H Gelman1, J Zhang, E Hailman, H Hanafusa, S S Morse.   

Abstract

We have developed sets of degenerate oligonucleotides designed to detect pol gene sequences from any member of the lentivirus subfamily when used as primers in amplification techniques such as the polymerase chain reaction (PCR). This pan-lentivirus-specific primer set (PLSPS) consists of primers, LV1, LV2, and LV3, based on conserved regions common to lentiviruses only. Our protocol is based on primary amplification with LV1 and LV2 followed by secondary amplification with a nested primer set based on the YM/VDD motif found in all reverse transcriptases (or "DDMY," in the opposite direction), and LV3, a block of lentivirus homology nested just downstream of LV1. PLSPS-PCR analysis of DNA from cells infected with HIV-1, HIV-2, SIVmac239, BIV, visna, EIAV, CAEV, OPPV, or FIV resulted in the amplification of appropriately sized products. Sequence analysis of the LV1/2 products, cloned into pBluescript (pBS), indicated that at least 20% (most often, > 80%) contained the predicted lentivirus pol sequence. Greater than 95% of the LV3/DDMY products contained the expected lentiviral sequences. Using the PLSPS, lentivirus pol sequences could typically be detected at levels of one copy in 2 x 10(6) cells after secondary amplification. No specific lentiviral PCR products were detected in DNA from uninfected human or mouse monocytes, feline or bovine leukocytes, mouse, rat or human fibroblast cell lines, chicken embryo fibroblasts, Tahr lung cells, or cell lines infected with the following retroviruses which are not lentiviruses: Rous sarcoma virus, Moloney leukemia virus or Kirsten sarcoma virus, mouse mammary tumor virus, human T-cell lymphotropic virus I, and feline leukemia virus.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1337258     DOI: 10.1089/aid.1992.8.1981

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  7 in total

1.  Lack of evidence of conserved lentiviral sequences in pigs with post weaning multisystemic wasting syndrome.

Authors:  A Bratanich; M Lairmore; W Heneine; C Konoby; J Harding; K West; G Vasquez; G Allan; J Ellis
Journal:  Can J Vet Res       Date:  1999-07       Impact factor: 1.310

2.  Characterization of a novel simian immunodeficiency virus (SIV) from L'Hoest monkeys (Cercopithecus l'hoesti): implications for the origins of SIVmnd and other primate lentiviruses.

Authors:  V M Hirsch; B J Campbell; E Bailes; R Goeken; C Brown; W R Elkins; M Axthelm; M Murphey-Corb; P M Sharp
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

3.  Isolation of a highly cytopathic lentivirus from a nondomestic cat.

Authors:  M C Barr; L Zou; D L Holzschu; L Phillips; F W Scott; J W Casey; R J Avery
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 4.  HIV-associated neurocognitive disorder--pathogenesis and prospects for treatment.

Authors:  Deanna Saylor; Alex M Dickens; Ned Sacktor; Norman Haughey; Barbara Slusher; Mikhail Pletnikov; Joseph L Mankowski; Amanda Brown; David J Volsky; Justin C McArthur
Journal:  Nat Rev Neurol       Date:  2016-03-11       Impact factor: 42.937

5.  Characterization of a novel simian immunodeficiency virus (SIVmonNG1) genome sequence from a mona monkey (Cercopithecus mona).

Authors:  Katrina L Barlow; Adebowale Oluwafemi Ajao; Jonathan P Clewley
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

Review 6.  Human RNA "rumor" viruses: the search for novel human retroviruses in chronic disease.

Authors:  Cécile Voisset; Robin A Weiss; David J Griffiths
Journal:  Microbiol Mol Biol Rev       Date:  2008-03       Impact factor: 13.044

Review 7.  A role for arrays in clinical virology: fact or fiction?

Authors:  Jonathan P Clewley
Journal:  J Clin Virol       Date:  2004-01       Impact factor: 3.168

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.